WO2002009763A3 - Transdermal drug delivery system - Google Patents

Transdermal drug delivery system Download PDF

Info

Publication number
WO2002009763A3
WO2002009763A3 PCT/IL2001/000630 IL0100630W WO0209763A3 WO 2002009763 A3 WO2002009763 A3 WO 2002009763A3 IL 0100630 W IL0100630 W IL 0100630W WO 0209763 A3 WO0209763 A3 WO 0209763A3
Authority
WO
WIPO (PCT)
Prior art keywords
delivery system
drug delivery
transdermal drug
pyretic
analgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2001/000630
Other languages
French (fr)
Other versions
WO2002009763A2 (en
Inventor
Amnon Sintov
Raphael Gorodischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ben Gurion University of the Negev Research and Development Authority Ltd
Ben Gurion University of the Negev BGU
Original Assignee
Ben Gurion University of the Negev Research and Development Authority Ltd
Ben Gurion University of the Negev BGU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ben Gurion University of the Negev Research and Development Authority Ltd, Ben Gurion University of the Negev BGU filed Critical Ben Gurion University of the Negev Research and Development Authority Ltd
Priority to EP01949852A priority Critical patent/EP1307231A2/en
Priority to AU2001270963A priority patent/AU2001270963A1/en
Priority to CA002417275A priority patent/CA2417275A1/en
Publication of WO2002009763A2 publication Critical patent/WO2002009763A2/en
Publication of WO2002009763A3 publication Critical patent/WO2002009763A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides a transdermal delivery system for analgesic, anti-pyretic and anti-inflammatory drugs comprising an analgesic, anti-pyretic or anti-inflammatory drug in combination with water-miscible tetraglycol and water for dissolving the drug in hydrogel form.
PCT/IL2001/000630 2000-07-27 2001-07-10 Transdermal drug delivery system Ceased WO2002009763A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01949852A EP1307231A2 (en) 2000-07-27 2001-07-10 Transdermal drug delivery system
AU2001270963A AU2001270963A1 (en) 2000-07-27 2001-07-10 Transdermal drug delivery system
CA002417275A CA2417275A1 (en) 2000-07-27 2001-07-10 Transdermal drug delivery system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL137559 2000-07-27
IL137559A IL137559A (en) 2000-07-27 2000-07-27 Transdermal drug delivery system

Publications (2)

Publication Number Publication Date
WO2002009763A2 WO2002009763A2 (en) 2002-02-07
WO2002009763A3 true WO2002009763A3 (en) 2002-04-18

Family

ID=11074457

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2001/000630 Ceased WO2002009763A2 (en) 2000-07-27 2001-07-10 Transdermal drug delivery system

Country Status (6)

Country Link
US (1) US20030170296A1 (en)
EP (1) EP1307231A2 (en)
AU (1) AU2001270963A1 (en)
CA (1) CA2417275A1 (en)
IL (1) IL137559A (en)
WO (1) WO2002009763A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050226910A1 (en) * 2002-06-20 2005-10-13 Amnon Sintov Transdermal drug delivery system
ES2535045T3 (en) 2003-04-10 2015-05-04 Vanderbilt Royalty Sub L.P. Uses and compositions for capsaicin administration
US8157788B2 (en) * 2003-11-06 2012-04-17 Paolo L. Manfredi Multi-site drug delivery platform
JP2007538010A (en) * 2004-05-07 2007-12-27 ファイトトックス リミテッド Transdermal administration of phycotoxin
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
SI1814531T1 (en) 2004-10-21 2010-10-29 Durect Corp Transdermal delivery systems
DE102005021806A1 (en) * 2005-05-04 2006-11-16 Lancaster Group Gmbh Use of radical-scavenging substances for the treatment of conditions with increased skin temperature, in particular for antipyretic treatment
US20070065494A1 (en) * 2005-08-03 2007-03-22 Watson Laboratories, Inc. Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
EP2155175B1 (en) * 2007-06-08 2014-03-12 Samyang Biopharmaceuticals Corporation Matrix-type transdermal drug delivery system and preparation method thereof
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
US8784872B2 (en) 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
WO2009158667A2 (en) * 2008-06-27 2009-12-30 Comgenrx, Inc. Povidone compositions for wound healing
CN102256602A (en) * 2008-10-21 2011-11-23 诺沃德米克斯国际有限公司 Compositions for treating epithelial tissue
IT1397246B1 (en) * 2009-05-14 2013-01-04 Fidia Farmaceutici NEW MEDICATIONS FOR TOPIC USE BASED HYALURONIC ACID SULFATED AS AN ACTIVATING OR INHABITING CITHOCINIC ACTIVITY
EP4522120A1 (en) 2022-06-03 2025-03-19 Dow Global Technologies LLC Formulation for transdermal delivery

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917886A (en) * 1982-10-07 1990-04-17 Ciba-Geigy Corporation Novel topically administrable pharmaceutical compositions
WO1991016929A1 (en) * 1990-05-10 1991-11-14 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
US5314915A (en) * 1991-09-25 1994-05-24 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
WO1997042987A1 (en) * 1996-05-13 1997-11-20 Ben-Gurion University Of The Negev Composition and method for forming biodegradable implants in situ and uses of these implants
WO1998020872A1 (en) * 1996-11-14 1998-05-22 Halldor Thormar Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
US5985860A (en) * 1992-06-03 1999-11-16 Toppo; Frank System for transdermal delivery of pain relieving substances
FI950345A7 (en) * 1992-07-27 1995-01-26 Procter & Gamble Laminated dual-textured nursing pads
IT1291362B1 (en) * 1997-05-13 1999-01-07 Vectorpharma Int BIPHASIC MULTICOMPONENT PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTANCES SUITABLE TO MODIFY THE PARTITION OF THE ACTIVE SUBSTANCES
US6348212B2 (en) * 1999-05-18 2002-02-19 Lectec Corporation Treating traumatic burns or blisters of the skin
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
US20050226910A1 (en) * 2002-06-20 2005-10-13 Amnon Sintov Transdermal drug delivery system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917886A (en) * 1982-10-07 1990-04-17 Ciba-Geigy Corporation Novel topically administrable pharmaceutical compositions
WO1991016929A1 (en) * 1990-05-10 1991-11-14 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
US5314915A (en) * 1991-09-25 1994-05-24 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
WO1997042987A1 (en) * 1996-05-13 1997-11-20 Ben-Gurion University Of The Negev Composition and method for forming biodegradable implants in situ and uses of these implants
WO1998020872A1 (en) * 1996-11-14 1998-05-22 Halldor Thormar Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections

Also Published As

Publication number Publication date
AU2001270963A1 (en) 2002-02-13
WO2002009763A2 (en) 2002-02-07
IL137559A0 (en) 2001-07-24
US20030170296A1 (en) 2003-09-11
IL137559A (en) 2006-12-31
EP1307231A2 (en) 2003-05-07
CA2417275A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
AU2002241538A1 (en) Intrasvascular drug delivery device and use therefor
AU2002255235A1 (en) Inflatable medical device with combination cutting elements and drug delivery conduits
WO2002009763A3 (en) Transdermal drug delivery system
MXPA03003957A (en) Transdermal drug delivery system with improved water absorbability and adhesion properties.
AU2001277120A1 (en) Drug delivery and catheter systems, apparatus and processes
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
AU2003265226A1 (en) Transdermal drug delivery device, method and use
MXPA03005044A (en) Reversible gelling system for ocular drug delivery.
WO2003084520A3 (en) Pharmaceutical preparation containing oxycodone and naloxone
AU2002363998A1 (en) Bioadhesive drug delivery system with enhanced gastric retention
AU4194799A (en) Multimolecular devices, drug delivery systems and single-molecule selection
AU7839900A (en) Reusable medication delivery device
AU4947100A (en) Drug delivery device
IL159415A0 (en) Enhanced drug delivery in transdermal systems
AU2001238386A1 (en) Medication delivery devices
AU2003217531A1 (en) Ocular drug delivery systems and use thereof
AU2002339993A1 (en) P-amidobenzylethers in drug delivery agents
AU2001227723A1 (en) Combined diffusion/osmotic pumping drug delivery system
AU2002353444A1 (en) Integrated transdermal drug delivery system
AU2001283357A1 (en) Drug delivery system with bilayer electrodes
AU2001244713A1 (en) Transporters and drug delivery system by using the same
EE05415B1 (en) Drug delivery device, in particular for the administration of androgens
AU3837999A (en) Drug delivery device
AU2003212962A1 (en) Transdermal drug delivery systems

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2417275

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001949852

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10343008

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001949852

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP